Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists

Herman, Alexandra; McCauley, Grace; Thaxton, Lauren; Borrego, Matthew E.; Sussman, Andrew L.; Espey, Eve

doi:10.1016/j.japh.2020.02.026

Cited by 11 publications

(12 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the studies included in this review, 38.1% (n = 8) explored how pharmacist-prescribed hormonal contraceptive services have been implemented. [37][38][39][40][41][42][43][44] Six of the eight studies focusing on implementation assessed pharmacists' perceptions of barriers and facilitators for providing pharmacist-prescribed hormonal contraceptive services. [37][38][39][40]42,44 Facilitators, motivators, and common barriers identified in the studies included in this review can be found in Table 3.…”

Section: Methodsmentioning

confidence: 99%

Pharmacist‐prescribed hormonal contraception services: A systematic review of implementation studies

Newlon

Reed

Stone

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

As of July 2021, 16 states and Washington DC permit pharmacist prescribing of hormonal contraceptives. The objective of this systematic review is to describe the impact of pharmacist prescribing on hormonal contraceptive access in the United States (U.S.). Using a protocol based on PRISMA guidelines, a librarian performed the literature search for articles published between January 1, 2013 and January 15, 2021. Studies were excluded if they were incomplete (ie, without results) or the full text was not available. Studies that took place outside of the U.S., within the U.S. but in a state that had not implemented pharmacist contraception prescribing at the time the research was initiated, or not written in English, as well as those that were not primary literature (ie, reviews, editorials, opinion papers, etc.) were also excluded from this review. Articles were categorized based on whether the outcomes evaluated (a) uptake of pharmacist-prescribed hormonal contraceptive services, (b) implementation of pharmacist-prescribed hormonal contraceptive services, or (c) impact of pharmacist-prescribed hormonal contraceptive services on patients' access to hormonal contraception. Of 2056 identified articles, 21 articles met the inclusion criteria and were included in the analysis. The majority (n = 16) assessed uptake of the service, whereas eight examined implementation and three evaluated impact of the service on patients' access. More research is warranted on the impact of pharmacist prescribing on patients' access to hormonal contraceptives.

show abstract

Section: Methodsmentioning

confidence: 99%

Pharmacist‐prescribed hormonal contraception services: A systematic review of implementation studies

Newlon

Reed

Stone

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…[45][46][47] Pharmacists and student pharmacists are strongly interested in participating in contraception care, increasing direct patient care services and facilitating patient access to a public health intervention. 21,[48][49][50][51][52][53] There are now over 3500 pharmacies in 18 states offering pharmacy access to contraception, although this is less widespread than desired. 54 For example, while only 5% to 11% of community pharmacies were offering pharmacistprescribed contraception in California after 1 year, that increased to approximately 25% after 4 years.…”

Section: Conduct Pharmacy Practice Researchmentioning

confidence: 99%

Enhancing access to contraception through pharmacist prescribing across Canada

et al. 2021

View full text Add to dashboard Cite

“…A key barrier to the adoption of contraceptive prescribing by pharmacists is adequate reimbursement for the time spent delivering this service. 6,7,26,35 A study conducted in Oregon reported that pharmacists spend an average of 26 minutes providing contraceptive prescriptions for each patient seen. 18 The time needed to comply with regulatory guidelines associated with prescribing contraceptives may not be commensurate with the reimbursement available to pharmacies for providing this service.…”

Section: Limitations Of the Policymentioning

confidence: 99%

“…In a study that conducted interviews in New Mexico, pharmacists reported uncertainty with the reimbursement associated with this service and believed that they do not receive payment for the majority of the work involved in the provision of contraceptive prescriptions. 35 In some cases, this service may not be paid for at all. A study analyzing 676 separate visits of contraceptive pharmacist-prescribing in California and Oregon reported that 16% of the patients did not have insurance.…”

Section: Limitations Of the Policymentioning

confidence: 99%

“…7,32 A study conducted in New Mexico reported that most of the pharmacists studied think that a fee between $30 and $60 may fairly compensate them for the service they provide. 35 However, this fee may be charged out of pocket for the patients. 25,32 California pharmacists reported that patients may not know that pharmacists charge a fee for contraceptive prescribing and that patients may not be able to pay for it.…”

Section: Limitations Of the Policymentioning

confidence: 99%

See 1 more Smart Citation

Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement

Facciolo

Farley

2021

Innov Pharm

View full text Add to dashboard Cite

In August 2020, pharmacists were authorized to prescribe contraceptives in Minnesota outside of a collaborative practice agreement. To practice under this new authorization, pharmacists must complete formal contraceptive prescribing training and follow guidelines which include restrictions on patient’s age and appropriate screening and assessment requirements. Allowing pharmacists to prescribe contraceptives has the potential to extend contraceptive access, decrease overall health care costs, and improve outcomes. However, barriers to the expansion of contraceptive prescribing by pharmacists may prevent widespread adoption of this practice in Minnesota. A key concern among pharmacists is a lack of reimbursement for providing this service. Other states adopting contraceptive prescribing by pharmacists which have not paid for this service have reported limited implementation and discontinuation of this service. To improve contraceptive access to Minnesotans, policymakers should consider expanding provider status to pharmacists and providing reimbursement to pharmacists for contraceptive services.

show abstract

Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists

Cited by 11 publications

References 12 publications

Pharmacist‐prescribed hormonal contraception services: A systematic review of implementation studies

Pharmacist‐prescribed hormonal contraception services: A systematic review of implementation studies

Enhancing access to contraception through pharmacist prescribing across Canada

Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement

Contact Info

Product

Resources

About